Volume 3, Issue 9: Controversies in Biologic Therapy for Psoriasis

eMedical Dermatology Review is a monthly CE series for the Dermatology nurse and health care professional. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 3, Issue 9)

 

Target Audience

Dermatology nurses and health care professionals

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to: 

 

  • Recognize that continuation of methotrexate in patients who are starting biologic therapy because of inadequate response to methotrexate may enhance efficacy.

  • Determine optimal therapy for patients who lose their response to biologics.

  • Discuss the impact of biologic treatment for moderate to severe psoriasis on cardiovascular risk.

 

 

Additional information
Contact email: 
ijhn@jhmi.edu
Course summary
Available credit: 
  • 1.00 ANCC
Registration opens: 
10/18/2012
Registration closes: 
10/17/2014
Cost:
$0.00
Lyn C. Guenther, MD FRCPC
Professor of Dermatology
The University of Western Ontario
London, Ontario
Canada
 

Available Credit

  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.